On Wednesday, the Food and Drug Administration (FDA) issued a statement granting additional exemptions from its November 27, 2024 deadline for compliance with certain product transaction requirements. The exemptions followed...more
In response to the opioid epidemic, many states, including Texas, created prescription drug monitoring programs to monitor high-risk patients and provider behaviors. The Texas Prescription Drug Monitoring Program (“PMP”) is...more
2/18/2020
/ Compliance Monitoring ,
Controlled Substances ,
Databases ,
Dentists ,
Document Retention Policies ,
Drug & Alcohol Abuse ,
Drug Distribution ,
Health Care Providers ,
Healthcare Reform ,
Opioid ,
Pain Management ,
Pharmaceutical Industry ,
Pharmacies ,
Physician Assistants ,
Physicians ,
Prescribing Authority ,
Prescription Drugs ,
Public Health ,
Public Safety ,
Regulatory Requirements ,
Risk Management ,
Substance Abuse
The U.S. Department of Health and Human Services, Office of Inspector General (“OIG”) recently released Advisory Opinion 18-10, which approved a proposed arrangement involving a manufacturer of medical devices and wound care...more